Chemotherapy and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia

NCT00002592 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

BIOLOGICAL: c-myb antisense oligonucleotide G4460
BIOLOGICAL: filgrastim
DRUG: busulfan
DRUG: cyclophosphamide
PROCEDURE: autologous bone marrow transplantation
PROCEDURE: in vitro-treated bone marrow transplantation

Sponsor

Abramson Cancer Center at Penn Medicine

Collaborators

[object Object]